Lucid Diligence Brief: BioNTech DualityBio BNT324 Phase 3 mCRPC
Lucid Diligence Brief: BioNTech DualityBio BNT324 Phase 3 mCRPC Professional…
Lucid Diligence Brief: Astellas collaboration with Vir Biotechnology
Lucid Diligence Brief: Astellas collaboration with Vir Biotechnology…
Lucid Diligence Brief: Candel Therapeutics $100m funding for CAN-2409 in localized prostate cancer
Lucid Diligence Brief: Candel Therapeutics $100m funding for CAN-2409 in…
Oncology Today—January 12, 2026
This week’s Oncology update highlights major oncology regulatory milestones,…
Oncology Video Recap—January 5, 2026
This Oncology video recap covering news from the last thre weeks brings…
Lucid Diligence Brief: Johnson & Johnson acquires Halda Therapeutics
Lucid Diligence Brief: Johnson & Johnson acquires Halda Therapeutics…
Oncology Today—December 15, 2025
This week’s oncology update spotlights key developments, regulatory milestones,…
Lucid Diligence Brief: Johnson & Johnson acquires Halda Therapeutics
Lucid Diligence Brief: Johnson & Johnson acquires Halda Therapeutics…
Lucid Diligence Brief: GSK and Syndivia preclinical ADC in mCRPC
Lucid Diligence Brief: GSK and Syndivia preclinical ADC in mCRPC Professional…
Advanced Prostate Cancer ARPIs: Efficacy, Safety, and Market Sentiment in an AI-Driven Search World
As AI reshapes how people discover health information, knowing how models…
Public Health Weekly News - September 12th 2025
Public Health Updates: Childhood Obesity, Chronic Disease Trends, And Cannabis…
Oncology Weekly News - September 1st 2025
🔬🧬 Oncology Updates: Tevimbra EU Approval, KRAS G12C Fast Tracks, HER2-Low…